Clinical Trial Update: LS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update indicates that the LS301-IT study for partial mastectomy and sentinel lymph node biopsy in ductal carcinoma in situ or Stage I-II inv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ductal Carcinoma in Situ
• Invasive Ductal Carcinoma of the Breast

Drugs mentioned

• LS301-IT

Snippet

Sponsor: Integro Theranostics | Conditions: Breast Cancer, DCIS | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING